Bringing diarrhea under CONTROL: dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer-MedSci.cn

Bringing diarrhea under CONTROL: dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer

Ruiz-Borrego, M; Chan, A; Marx, G; Brufsky, A; Trudeau, M; Egle, D; McCulloch, L; Tripathy, D; Barcenas, CH

BREAST, 2021; 56 (): S18

科室
- - 订阅+
  - 更多科室
工具
服务